This also supports the need for individualized, dynamic care plans for patients with MCT8 deficiency, provided by an integrated multidisciplinary care team tailored to each patient’s unique symptomatic presentation [19]. The gene discussed is SLC16A2; the disease is hyperinsulinemic hypoglycemia, familial, 4.